ORaClES: A Trial to Improve Prognostication
ORaClES
Online Randomised Controlled Trial to Improve Clinical Estimates of Survival (ORaClES)
1 other identifier
interventional
170
1 country
5
Brief Summary
This study evaluates whether an online training resource can improve the performance of medical students in recognising imminently dying palliative care patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2017
CompletedFirst Posted
Study publicly available on registry
December 4, 2017
CompletedStudy Start
First participant enrolled
April 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 12, 2018
CompletedApril 10, 2020
April 1, 2020
4 months
November 23, 2017
April 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival estimates - immediate effect
The primary outcome will be a continuous survival estimate provided from the students for the second series of vignettes; ranging from 0-100%.
Second series of vignettes, taking into account the estimates from the first series. Students can participate at their convenience and will have a four week window to complete the first and second series of vignettes.
Secondary Outcomes (3)
Survival estimates - follow-up
Third series of vignettes, taking into account the estimates from previous series. Two weeks after completing the first and second series of vignettes, students will be asked to complete a third series of vignettes within a four week window.
Cue weighting
Change over time including all three series of vignettes. Students are given a four week window to complete the first and second series of vignettes. After two weeks, they will be asked to complete a third series of vignettes within a four week window.
Level of expertise
Change over time including all three series of vignettes. Students are given a four week window to complete the first and second series of vignettes. After two weeks, they will be asked to complete a third series of vignettes within a four week window.
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention is an online training resource to improve the recognition of imminent death in palliative care patients. The intervention should take approximately 15 minutes to complete. During this time, the participants who are in the intervention arm will be shown the results of a previous study which identified how expert palliative care doctors recognise imminently dying palliative care patients. The intervention will be implemented via the website, immediately after participants have completed the first set of vignettes.
Control group
NO INTERVENTIONThe participants assigned to the control group will not receive this additional information and will simply be informed that they are approximately half way through the task and will be asked to continue on to the next set of vignettes.
Interventions
Please see information included in the description of the intervention group.
Eligibility Criteria
You may qualify if:
- Over 18 years of age
- Enrolled on a registered medical course within the United Kingdom
- In the penultimate or final year of medical school
- Sufficient English language proficiency
- Willing and able to provide consent as indicated by taking part in the online survey
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University College, Londonlead
- Brunel Universitycollaborator
- Imperial College Londoncollaborator
- Marie Curie Hospice, Belfastcollaborator
- Hull York Medical Schoolcollaborator
Study Sites (5)
Brighton and Sussex Medical School
Brighton, United Kingdom
Hull York Medical School
Hull, United Kingdom
Imperial College London
London, United Kingdom
St George's Medical School
London, United Kingdom
UCL Medical School
London, United Kingdom
Related Publications (2)
Oostendorp L, White N, Harries P, Yardley S, Tomlinson C, Ricciardi F, Gokalp H, Stone P. Protocol for the ORaClES study: an online randomised controlled trial to improve clinical estimates of survival using a training resource for medical students. BMJ Open. 2019 Mar 3;9(3):e025265. doi: 10.1136/bmjopen-2018-025265.
PMID: 30833321BACKGROUNDWhite N, Oostendorp LJ, Tomlinson C, Yardley S, Ricciardi F, Gokalp H, Minton O, Boland JW, Clark B, Harries P, Stone P. Online training improves medical students' ability to recognise when a person is dying: The ORaClES randomised controlled trial. Palliat Med. 2020 Jan;34(1):134-144. doi: 10.1177/0269216319880767. Epub 2019 Nov 14.
PMID: 31722611BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Stone, PhD, MD
UCL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2017
First Posted
December 4, 2017
Study Start
April 5, 2018
Primary Completion
July 27, 2018
Study Completion
August 12, 2018
Last Updated
April 10, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will become available after the publication of results and will be archived securely by the Chief Investigator for a minimum of 20 years from the declaration of end of trial.
- Access Criteria
- The data will be shared upon reasonable request.
Data (suitably anonymised) may be shared with other research groups if a reasonable request is submitted to and agreed by the Chief Investigator.